Shaanxi Bolin Biotechnology Co.,Ltd
New antimalarial drug - artemisinin
Malaria is one of the most serious infectious diseases in the world, with approximately 250 million people suffering from the disease each year and 850,000 people dying from malaria. The World Health Organization (WHO) estimates that about half of the world's population is at risk of contracting malaria, and that living in low-income countries is even more dangerous.
On October 8, 2015, Chinese scientist Tu Yu won the 2015 Nobel Prize in Physiology or Medicine and creatively developed new antimalarial drugs, artemisinin and dihydroartemisinin, which achieved 100% inhibition of Plasmodium.
Artemisinin is a colorless needle-like crystal of a sesquiterpene lactone having a peroxy group extracted from the stems and leaves of the compound inflorescence plant Artemisia annua.
The main effects of artemisinin are:
1. Artemisinin and its derivatives can quickly eliminate the malaria parasite in human body and have a good therapeutic effect on falciparum malaria.
2. It is mainly used for the control of symptoms of vivax malaria, falciparum malaria, and the treatment of chloroquine-resistant strains. It can also be used to treat violent malaria, such as brain type and jaundice type. It can also be used to treat systemic lupus erythematosus and discoid lupus erythematosus.
If you want to know more information , please contact us .
Copyright © Shaanxi Bolin Biotechnology Co.,Ltd All Rights Reserved.